carbostyril has been researched along with Abnormalities, Congenital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beeker, N; Chouchana, L; Treluyer, JM | 1 |
| Bar-Oz, B; Boskovic, R; Koren, G; Moretti, ME; O'Brien, L | 1 |
1 review(s) available for carbostyril and Abnormalities, Congenital
| Article | Year |
|---|---|
The safety of quinolones--a meta-analysis of pregnancy outcomes.
Topics: Anti-Infective Agents; Congenital Abnormalities; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Quinolones; Risk Factors; Stillbirth | 2009 |
1 other study(ies) available for carbostyril and Abnormalities, Congenital
| Article | Year |
|---|---|
Is There a Safety Signal for Dolutegravir and Integrase Inhibitors During Pregnancy?
Topics: Adult; Anti-Retroviral Agents; Cohort Studies; Congenital Abnormalities; Drug Resistance, Viral; Female; France; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Neural Tube Defects; Oxazines; Pharmacovigilance; Piperazines; Pregnancy; Pyridones; Quinolones; Raltegravir Potassium; Treatment Outcome; Young Adult | 2019 |